Special Dosing Considerations
For many patients the average dose range for a given drug can be toxic. The purpose of this section is to describe vulnerable patient populations for which special dosing considerations must be made to protect the patient and improve clinical outcomes.
There's more to see -- the rest of this topic is available only to subscribers.
Vallerand, April Hazard., et al. "Special Dosing Considerations." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations.
Vallerand AHA, Sanoski CAC, Quiring CC. Special Dosing Considerations. Davis's Drug Guide. F.A. Davis Company; 2023. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations. Accessed June 3, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Special Dosing Considerations. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations
Vallerand AHA, Sanoski CAC, Quiring CC. Special Dosing Considerations [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 June 03]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Special Dosing Considerations ID - 109953 A1 - Sanoski,Cynthia A, AU - Vallerand,April Hazard, AU - Quiring,Courtney, BT - Davis's Drug Guide UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations PB - F.A. Davis Company ET - 18 DB - Emergency Central DP - Unbound Medicine ER -